We take your privacy seriously - your data is encrypted, kept secure, and we're ICO approved.
Clinically reviewed

One app. Built for Mounjaro.

Whether you're taking Mounjaro for diabetes, weight management, or both — track doses, log side effects, hit your protein goals, and see your progress. Everything you need, in one app.

“I finally feel like I have a handle on everything. The protein tracking alone changed how I eat.”

Sarah, 38

“My doctor was impressed I had everything logged. Side effects, doses, weight. Made the appointment so much more productive.”

Amy, 46

7-day free trial. Cancel anytime.

AI Protein Tracking

Snap. Track. Done.

Take a photo of your meal and Lina breaks it down. Protein, calories, and macros in seconds. On Mounjaro, getting enough protein is everything. Lina makes it effortless.

Side Effect Logging

"Is this normal?"

Nausea, fatigue, headaches. Mounjaro side effects can be confusing. Log what you feel, when you feel it, and start spotting patterns your doctor will actually want to see.

Injection Reminders

Never forget a dose.

Set reminders for your Mounjaro injection day. Track which site you used, rotate properly, and keep a clean record of every dose.

Daily Insights

900+ insights built for this journey.

Not generic wellness tips. Real, clinically-reviewed content written specifically for people on Mounjaro. From what to eat to how to manage plateaus.

Weight Tracking

The scale lies. Trends don't.

Weight fluctuates. Lina shows you the trend, not the noise. See your progress over weeks and months, overlaid with your dose timeline so you can see what is working.

Everything Included

The stuff nobody else does

AI meal photo tracking
Protein & calorie logging
Side effect tracking
Injection site rotation
Dose reminders & scheduling
Weight trend graphs
Daily check-ins with streaks
900+ GLP-1 insights
Progress photos
Water tracking
Glucose monitoring
Home exercise library
Export data for your doctor

Why Mounjaro?

Mounjaro (tirzepatide) is the first dual GLP-1 and GIP receptor agonist approved for both type 2 diabetes and weight management. In the SURMOUNT-1 trial, participants lost an average of 20.9% of their body weight over 72 weeks, with more than one-third losing over 25%.

In the SURPASS-2 trial, Mounjaro showed superior results compared to Ozempic (semaglutide 1 mg) for both blood sugar control and weight loss in people with type 2 diabetes. The dual-agonist mechanism targets both GLP-1 and GIP pathways, offering benefits that go beyond what single-agonist medications can achieve.

Whether you are on Mounjaro for diabetes, weight loss, or both, consistent tracking of your doses, meals, and side effects is essential to getting the best results. Lina was built for exactly this.

References:
Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022;387(3):205-216.
Frías JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med 2021;385(6):503-515.

Frequently asked questions